Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
The DARK Side of MSL-ing-What No One Tells YOU
Summary
In this episode, Kirsten Gurtowsky shares her experiences and insights as a Medical Science Liaison. She discusses her career journey, highlighting the balance and flexibility required in the MSL role, as well as the challenges faced. Kirsten delves into the importance of building strong relationships with Key Opinion Leaders and offers strategies for successful networking and engagement. She also provides guidance for aspiring MSLs, drawing on her professional experiences. The episode concludes with Kirsten sharing her excitement and goals for the upcoming year, followed by expressions of appreciation.
Kirsten Gurtowsky, Medical Science Liaison with Novartis, discusses the dark side of being an MSL and what you may not be aware of
Kirsten shares….
👉 What she LOVES about being an MSL
👉 What some of the main frustrations are for MSLs
👉 The challenges of travel and uncertainty
👉 The frustrations that come with paperwork and metrics
👉 Her insights and predictions for 2024
Medical Science Liaison, Key Opinion Leaders, career journey, challenges faced, successful networking
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO